Venture capital firm Greylock Partners introduced Greylock 18, a new $1.5 billion venture fund aimed at investing at the ...
An AI-native pharmaceutical company headquartered in New York City, with additional operational hubs across Boston, the San Francisco Bay Area, and North Carolina’s Research Triangle. The company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results